43 results on '"Cornford P"'
Search Results
2. Development of a predictive model for death amongst patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) treated with one of the approved treatment plans, on characteristics present at admission using Big data: Preliminary results from the European network of excellence for big data in prostate cancer (PIONEER)
3. Patient- and tumour-related prognostic factors for urinary incontinence after radical prostatectomy for nonmetastatic prostate cancer: A systematic review and meta-analysis
4. Development of prostate cancer typical case presentations and their usage in OPTIMA’s guideline based decision support tool
5. AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer
6. OPTIMA prostate cancer care pathways - bridging clinical practice guidelines, real world evidence and artificial intelligence to enhance decision-making
7. Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric MRI (PIRADS/Likert 3-5) and negative initial biopsy. A systematic review
8. Analysis of clinical characteristics in metastatic hormone-sensitive prostate cancer: Bridging the gap between randomized controlled trials and real-world data
9. Real-world data analysis of treatment outcomes for patients with metastatic hormone-sensitive prostate cancer: development of a survival prediction model. Results from the European network of excellence for big data in prostate cancer (PIONEER)
10. Real-world data analysis of clinical characteristics in metastatic hormone-sensitive prostate cancer: Are patients from RCTs the same from real life? Data from the European network of excellence for big data in prostate cancer (PIONEER).
11. Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding selection, monitoring and reclassification thresholds
12. A novel EAU Guidelines based clinicial decision support software – evaluation of Siemens AIPC Software in prostate cancer screening
13. Evaluation of oncological outcomes and data quality in studies assessing nerve sparing versus non-nerve sparing radical prostatectomy in non-metastatic prostate cancer: A systematic review
14. A systematic review on the impact of surgeon and hospital caseload volume on oncological and non-oncological outcomes after radical prostatectomy for non-metastatic prostate cancer
15. OC-0694: An ESTRO-ACROP Delphi consensus on salvage SBRT for intraprostatic relapse after PCa radiotherapy
16. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel consensus statements for active surveillance for localised prostate cancer from an international collaborative study (DETECTIVE study)
17. The EAU biochemical recurrence risk stratification after radical prostatectomy
18. EAU PCa Guideline Panel: Systematic review of focal ablative therapy for localised prostate cancer compared with standard therapies
19. Current treatment options for locally advanced prostate cancer: EAU (-SIOG) guidelines view and recommendations
20. Important barriers and facilitators for involving patients in guideline development and implementation for genitourinary cancers
21. The Success and Evolution of a Urological “Boot Camp” for Newly Appointed UK Urology Registrars: Incorporating Simulation, Nontechnical Skills and Assessment
22. Retrograde Stents as Alternative to Nephrostomy in Ureteral Obstruction in Cancer Patients: A Systematic Review and Meta-Analysis
23. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: A systematic review
24. EVOLVE: Designing a model of meaningful patient involvement in guideline development
25. An international collaborative study to develop consensus statements for deferred treatment with curative intent for localised prostate cancer
26. Care pathways for the management of metastatic and castration-resistant prostate cancer in the era of novel therapeutic options: Experience of the EAU guidelines office
27. Systematic review of quality of life outcomes after primary treatment for clinically localised prostate cancer
28. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis
29. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: A systematic review
30. Care pathways for the management of localised and locally advanced prostate cancer: Experience of the EAU guidelines office
31. First urology simulation boot camp in the United Kingdom
32. Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient–Nhs Interactions and Hospital Resource use: Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation)
33. PE25: Paradoxical lower positive margin rates seen in patients with D’Amico high risk prostate cancer compared to low/intermediate risk patients in robotic prostatectomy series
34. Hsp90 inhibition synergism with chemotherapeutic agents may act through Apaf-1 modulation in pancreatic cancer
35. Periurethral abscess complicating male gonococcal urethritis treated by surgical incision and drainage
36. Small Cell Prostate Cancer With Anti-hu Positive Peripheral Neuropathy
37. Massive Peri-renal Haemorrhage from Ruptured Renal Artery Aneurysm in the Presence of Normal Renal Function
38. TRANSURETHRAL INCISION OF THE PROSTATE USING THE HOLMIUM
39. Use of the Holmium: YAG laser for urethral stricture under topical anaesthesia
40. Emphysematous Cystitis
41. Risk-adjusted analysis of surgeon performance: A 1-year study
42. Human decidua is a target tissue for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro.
43. Transformation of porphobilinogen into porphyrins by preparations from human erythrocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.